← 返回
开发者工具 中文

Admet Prediction

ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) prediction for drug candidates. Use for assessing drug-likeness, PK properties, and safety...
用于候选药物的ADMET(吸收、分布、代谢、排泄、毒性)预测,以评估类药性、药代动力学性质及安全性。
huifer huifer 来源
开发者工具 clawhub v0.1.0 1 版本 99919.6 Key: 无需
★ 0
Stars
📥 1,243
下载
💾 23
安装
1
版本
#latest

概述

ADMET Prediction Skill

Predict ADMET properties to prioritize compounds for development.

Quick Start

/admet "CC1=CC=C(C=C1)CNC" --full
/pk-prediction --library compounds.sdf --threshold 0.7
/toxicity-screen CHEMBL210 --include hERG,DILI,Ames

What's Included

PropertyPredictionModel
-----------------------------
AbsorptionCaco-2, HIA, PgpML/QSAR
DistributionVDss, PPB, BBBML/QSAR
MetabolismCYP inhibition, clearanceML/QSAR
ExcretionClearance, half-lifeML/QSAR
ToxicityhERG, DILI, Ames, mutagenicityML/QSAR

Output Structure

# ADMET Profile: CHEMBL210 (Osimertinib)

## Summary
| Property | Value | Status |
|----------|-------|--------|
| Drug-likeness | Pass | ✓ |
| Lipinski Ro5 | 0 violations | ✓ |
| VEBER | Pass | ✓ |
| PAINS | 0 alerts | ✓ |
| Brenk | 0 alerts | ✓ |

## Absorption
| Property | Prediction | Confidence |
|----------|------------|-------------|
| HIA | 98% | High |
| Caco-2 | 15.2 × 10⁻⁶ cm/s | High |
| Pgp substrate | Yes | Medium |
| F30% | 65% | Medium |

## Distribution
| Property | Prediction | Confidence |
|----------|------------|-------------|
| VDss | 5.2 L/kg | Medium |
| PPB | 95% | High |
| BBB | Yes | High |
| CNS MPO | 5.5 | Good |

## Metabolism
| Property | Prediction | Confidence |
|----------|------------|-------------|
| CYP3A4 substrate | Yes | High |
| CYP3A4 inhibitor | Yes | Medium |
| CYP2D6 inhibitor | No | High |
| CYP2C9 inhibitor | No | Medium |
| Clearance | 8.5 mL/min/kg | Low |

## Excretion
| Property | Prediction | Confidence |
|----------|------------|-------------|
| Renal clearance | 10% | Medium |
| Half-life | 48 hours | High |

## Toxicity
| Property | Prediction | Confidence |
|----------|------------|-------------|
| hERG inhibition | No | High |
| DILI | Concern | Medium |
| Ames mutagenicity | Negative | High |
| Carcinogenicity | Negative | Medium |
| Respiratory toxicity | No | Low |

## Recommendations
**Strengths**:
- Good oral bioavailability (65%)
- Brain penetration (BBB permeable)
- Low hERG risk

**Concerns**:
- DILI concern - monitor in preclinical studies
- CYP3A4 inhibition - potential DDIs

**Overall**: Good ADMET profile. Progress to in vivo PK.

Property Ranges

Drug-Likeness

RulePass Criteria
---------------------
Lipinski Ro5≤ 1 violation
VeberRotB ≤ 10, PSA ≤ 140 Ų
EganLogP ≤ 5, PSA ≤ 131 Ų
MDDRMW ≤ 600, LogP ≤ 5

Absorption

PropertyGoodModeratePoor
--------------------------------
HIA>80%40-80%<40%
Caco-2>101-10<1
F30%>70%30-70%<30%

Distribution

PropertyGoodModeratePoor
--------------------------------
VDss0.3-5 L/kg<0.3 or >5Extreme
PPB<90%90-95%>95%
BBBLogBB > 0.3-0.3 to 0.3< -0.3

Toxicity Alerts

AlertAction
---------------
hERG inhibitionCardiotoxicity risk
DILI positiveHepatotoxicity risk
Ames positiveMutagenicity risk
PAINSAssay interference
Structural alertsInvestigate further

Running Scripts

# Full ADMET profile
python scripts/admet_predict.py --smiles "CC1=CC=C..." --full

# Batch prediction
python scripts/admet_predict.py --library compounds.sdf --output results.csv

# Specific properties
python scripts/admet_predict.py --smiles "..." --properties hERG,DILI,CYP

# Filter by criteria
python scripts/admet_filter.py --library compounds.sdf --rules lipinski,veber

Requirements

pip install rdkit

# Optional for advanced models
pip install deepchem admet-x

Reference

Best Practices

  1. Use multiple models: Consensus predictions more reliable
  2. Check confidence: Low confidence = experimental verification needed
  3. Consider chemistry: Novel structures less reliable
  4. Iterative design: Use predictions to guide synthesis
  5. Validate early: Confirm key predictions experimentally

Common Pitfalls

PitfallSolution
-------------------
Over-reliance on predictionsExperimental validation required
Ignoring confidenceCheck model applicability domain
Single model onlyUse consensus of multiple models
Ignoring chemistryNovel scaffolds = uncertain predictions
Late-stage testingEarly ADMET screening saves time

Limitations

  • Models are approximate: Errors common
  • Novel chemistry: Less reliable for new scaffolds
  • In vitro-in vivo gap: Predictions don't always translate
  • Species differences: Human predictions based on animal data
  • Complex mechanisms: Some toxicity not predicted

版本历史

共 1 个版本

  • v0.1.0 当前
    2026-03-29 05:45 安全 安全

安全检测

腾讯云安全 (Keen)

安全,无风险
查看报告

腾讯云安全 (Sanbu)

安全,无风险
查看报告

🔗 相关推荐

professional

A股量化 AkShare

mbpz
A股量化数据分析工具,基于AkShare库获取A股行情、财务数据、板块信息等。用于回答关于A股股票查询、行情数据、财务分析、选股等问题。
★ 178 📥 61,362
professional

Stock Analysis

udiedrichsen
{"answer":"基于雅虎财经数据,分析股票与加密货币。支持投资组合管理、自选股预警、股息分析、8维评分、热门趋势扫描及传闻/早期信号探测。适用于股票分析、持仓追踪、财报异动、加密监控、热门股追踪或提前发掘非主流传闻。"}
★ 273 📥 57,297
professional

All-Market Financial Data Hub

financial-ai-analyst
基于东方财富数据库,支持自然语言查询金融数据,覆盖A股、港股、美股、基金、债券等资产,提供实时行情、公司信息、估值、财务报表等,适用于投资研究、交易复盘、市场监控、行业分析、信用研究、财报审计、资产配置等场景,满足机构与个人需求。返回结果为
★ 118 📥 40,940